Longevity
Four medical societies map women's heart health across a lifetime
By Life and Health Today Staff, . Life and Health Today.
Cardiovascular disease is the leading cause of death in women, yet the clinical systems meant to prevent it were largely built around male biology. A new framework published Monday in the journal Circulation aims to change that by mapping four distinct stages of female heart health across a lifetime, from the first menstrual period through postmenopause, and connecting them into a single continuum of care.
The guidance was issued jointly by the American Heart Association, the American Academy of Pediatrics, the Society for Maternal-Fetal Medicine, and the American College of Obstetricians and Gynecologists. Three articles covering the full course of a woman's life appeared in the same issue.
Why the framework exists
The core problem the authors identified is fragmentation. Women typically see many different clinicians across their lives, and each specialty has tended to manage its own slice of health without connecting it to the others. Pregnancy complications, for example, have well-established links to later cardiovascular risk, but the handoff from postpartum care to long-term preventive care has historically been weak.
Sadiya Khan, who chaired the writing group and is a professor of cardiovascular epidemiology at Northwestern University Feinberg School of Medicine, told the publication that the goal was a shared playbook. "What happens in adolescence and young adulthood impacts your life for years and decades to come," she said, "so having action at that point can really change the course of someone's cardiovascular health story."
The four stages and what they flag
The framework begins at perimenarche, the period around a girl's first menstrual cycle, which the authors describe as the point where sex-specific medicine should begin. Heavy menstrual bleeding can cause iron deficiency, which can limit physical activity and affect cardiovascular health. Irregular cycles can also be an early signal of what was formerly called polycystic ovary syndrome and is now referred to as polyendocrine metabolic ovarian syndrome, a condition that often goes undiagnosed for years.
Pregnancy is the second stage. High blood pressure and diabetes during pregnancy are not only immediate risks but markers of cardiovascular vulnerability that can persist for decades afterward.
Perimenopause, the transition phase roughly between ages 45 and 51 when cycle length becomes variable and hormone levels shift, is identified as a cardiovascular inflection point. The guidance says changes in cholesterol and metabolic health during this window can be early signs of cardiovascular risk. Khan said that identifying and acting on those signs early may reduce the likelihood of cardiovascular disease later, though the framework is guidance rather than a clinical trial result.
Postmenopause is the fourth stage. The authors say it carries significant cardiovascular implications that warrant continued monitoring, not a return to routine care.
What connects them
The framework's central argument is that these stages are not separate events but a linked biological story. Hormone biology, the authors write, influences both the heart and the brain, which is why mental health, including rising rates of depression and anxiety in adolescent girls, belongs in the same conversation as cardiovascular risk. Structural factors, including higher rates of poverty among women, unequal pay, and single parenthood, are also named as contributors to cardiovascular health.
Khan drew a comparison to the Ages and Stages Questionnaire used in pediatrics, which gives parents a developmental roadmap for the first years of a child's life. The new framework attempts something similar across the full female lifespan: a shared language for clinicians and patients about what to expect, what is normal, and what warrants attention.
What the framework does not settle
This is guidance from professional societies, not a clinical trial. It does not establish that following the framework will reduce cardiovascular events, and the authors do not claim that it does. What it offers is a structure for care that currently does not exist in a unified form. Whether health systems adopt it, and whether adoption translates into better outcomes, are questions that will take years of implementation and study to answer.
For any woman weighing what this means for her own care, the relevant conversation is with a clinician who knows her history across these stages, not just the one she is in now.
Life & Health Today provides information for educational purposes only, not medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional.